Jiangsu Hengrui Medicine
600276.SS
#599
Rank
NZ$74.47 B
Marketcap
NZ$11.22
Share price
-0.67%
Change (1 day)
-31.50%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

EPS for Jiangsu Hengrui Medicine (600276.SS)

EPS in 2026 (TTM): NZ$0.25

According to Jiangsu Hengrui Medicine 's latest financial reports the company's current EPS (TTM) is NZ$0.26. In 2025 the company made an earnings per share (EPS) of NZ$0.30 an increase over its 2024 EPS that were of NZ$0.24.

EPS history for Jiangsu Hengrui Medicine from 2000 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$0.25-15.11%
2025NZ$0.3024.14%
2024NZ$0.2442.43%
2023NZ$0.178.77%
2022NZ$0.15-20.62%
2021NZ$0.19-26.59%
2020NZ$0.2627.24%
2019NZ$0.2128.41%
2018NZ$0.1620.04%
2017NZ$0.1331.21%
2016NZ$0.1011.46%
2015NZ$0.0921136.27%
2014NZ$0.0675919.77%
2013NZ$0.0564418.05%
2012NZ$0.0478123.9%
2011NZ$0.0385926.9%
2010NZ$0.0304112.37%
2009NZ$0.0270656.6%
2008NZ$0.017289.18%
2007NZ$0.01583114.48%
2006NZ$0.00737964.83%
2005NZ$0.00447735.55%
2004NZ$0.00330329.73%
2003NZ$0.00254619.86%
2002NZ$0.002124-2.71%
2001NZ$0.0021831.02%
2000NZ$0.002161